The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis
Abstract There has been a global increase in the use of cannabinoids as a treatment for mental health (MH) and substance use disorders (SUD). In 2016, an Australian government-funded review found that although medicinal cannabinoids accounted for a small reduction in MH symptoms, the results varied...
Saved in:
Main Authors: | Jack Wilson, Andrew Langcake, Zachary Bryant, Tom P. Freeman, Janni Leung, Gary C. K. Chan, Amir Englund, Myfanwy Graham, Emily Stockings |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Systematic Reviews |
Online Access: | https://doi.org/10.1186/s13643-024-02657-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabinoid Hyperemesis
by: Stephen Sullivan
Published: (2010-01-01) -
Cannabinoids for Pain Management: What is their Role?
by: Alexander J Clark, et al.
Published: (2005-01-01) -
Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01) -
The Contours of Locke’s General Substance Dualism
by: Graham Clay
Published: (2022-03-01) -
Cannabinoids in the Brain: New Vistas on an Old Dilemma
by: Maurice Ptito, et al.
Published: (2016-01-01)